Industry Reports
Novartis Q2 results enhance future growth prospects with eight significant regulatory milestones
Gilenya (USD 811 million, +17% cc) continued to grow double-digit mainly due to volume growth Cosentyx (USD 260 million) grew strongly driven by...
Industry Reports
Gilead Sciences to Release Second Quarter 2016 Financial Results on Monday, July 25, 2016
Gilead Sciences, Inc announced that its second quarter 2016 financial results will be released on Monday, July 25, after the market closes. At 4:30...
Industry Reports
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2016
Johnson & Johnson today announced that its Board of Directors has declared a cash dividend for the third quarter of 2016 of $0.80 per...
Industry Reports
Johnson & Johnson Announces Completion of Acquisition of Vogue International LLC
Johnson & Johnson announced that Johnson & Johnson Consumer Inc. has successfully completed the acquisition of Vogue International LLC, a privately-held company focused on...
News
Open House Marchesini Group: the countdown to the opening of the biggest thermoforming hub in Italy has begun
The Thermoforming Hub Open House of Marchesini Group is one of the most long-awaited events of next Autumn for the Italian pharmaceutical industry. The...
News
Allergan Plc Files Application to FDA for Approval of Oculeve Intranasal Tear Neurostimulator
Allergan plc announced that it has filed with the U.S. FDA the de novo application for the Oculeve Intranasal Tear Neurostimulator device. According to...
Press Releases
EMA accepts Merck’s MAA for cladribine tablets in multiple sclerosis
Merck, a leading science and technology company announced that the EMA to request the company for marketing approval for its investigational Cladribine Tablets for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read